Some neutralizing antibodies against HIV-1 envelope proteins were highly ef
fective to inhibit the infection of different strains in vitro, and existed
in the infected individuals with very low levels. We suggested multi-epito
pe-vaccine as a new strategy to increase levels of neutralizing antibodies
and the abilities against HIV mutation in vivo. Two candidate multi-epitope
-vaccines induced antibodies with predefined multi-epitope-specificity in r
hesus macaque. These antibodies recognized corresponding neutralizing epito
pes on epitope-peptides, gp41 peptides, V3 loop peptide, rsgp41 and rgp120.
Besides, three candidate epitope-vaccines in combination (another kind of
multi-epitope-vaccines) showed similar potency to induce predefined multipl
e immune responses in rabbits. These results suggest that multi-epitope-vac
cines may be a new strategy to induce multi-antiviral activities against HI
V-1 infection and mutations.